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Probiotics mediated gut microbiota
diversity shifts are associated with
reduction in histopathology and shedding
of Lawsonia intracellularis
Adrian Muwonge1, Anbu K. Karuppannan2 and Tanja Opriessnig1,3*
Abstract
Background: Clinical intervention during bacterial infections in farm animals such as pigs commonly includes the
use of antimicrobials. With the rise of antimicrobial resistance and the attempts to reduce the use of antibiotics in
food animals, effective alternatives are urgently needed to reduce or even remove pathogens and disease risks.
Improving clinical outcomes and overall pig health by using probiotics appears attractive. However, reliable data
sets on the efficacy of probiotics are scarce. The obligate intracellular bacterium Lawsonia intracellularis is
widespread in pigs and associated with severe enteropathy, mainly in the ileum, commonly resulting in substantial
reduction in weight gain. The impact of three in-feed probiotics and a commercial live L. intracellularis vaccine
was compared in a pig challenge model. Probiotic treatment was associated with reduced L. intracellularis fecal
shedding and reduced gut lesions. Here, the bacterial microbiota of the ileum of these pigs was characterized with
16S rRNA gene sequencing and was subsequently analyzed with bioinformatics tools.
Results: The greatest microbial richness was observed in the probiotic treated group T03-LAW, which accounted
for 87% of richness observed in the study. Treatment had a significant impact on both the microbiota structure and
taxonomic profile in the ileum, explaining between 26 and 36% of the structural variation, with the strongest
association in the T03-LAW group. Overall, the largest changes were observed for the pigs treated with in-feed
Bacillus pumilus; the microbiota of these pigs had the greatest diversity and highest richness. We also observed
depleted and enriched core microbiota amongst the groups; however, there was no correlation with clinical
characteristics. The results suggest that an increased diversity of the ileal microbiota is associated with a reduction
in shedding, i.e. a unit increase in Shannon diversity index resulted in 2.8 log reduction in shedding.
Conclusions: Probiotic supplementation of a base feed ration increased ileum microbiota diversity leading to a
mitigation of the effects of a pathogenic L. intracellularis challenge. An even and diverse microbiota community
benefits pigs infected with L. intracellularis, however, investigations are needed to determine if this is also true for
other pathogens. The study unambiguously demonstrates the usefulness of probiotic supplementation in reducing
the impact of enteric pathogens and pathogen shedding rates in food animals without the use of antimicrobials.
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Background
Probiotics are increasingly used in commercial food ani-
mal production and are also slowly being implemented
in pork production. Interactions of diet, gut microbiota,
and host appear to impact animal health and disease [1].
Common feed additives, such as dietary phytase supple-
mentation and lactic acid treatment of cereals, drastically
altered the bacterial community composition in feces of
growing pigs [2]. Probiotic supplementation is thought
to have a beneficial effect for pigs, however, its impact
on the gut microbiome itself is less clear and is yet to be
robustly investigated. Limited numbers of studies have
investigated the porcine gut microbiota in the context of
dietary changes. Dietary phytase supplementation af-
fected all major bacterial taxa, but reduced species rich-
ness and diversity in fattening pigs based on 16S rRNA
gene sequencing of fecal DNA [3]. Shifts in the compos-
ition of the fecal microflora, in response to the adminis-
tration of prebiotic lactulose, significantly increased the
Firmicutes-to-Bacteroidetes ratio in weaned pigs [4]. At
the family level, Lactobacillaceae numbers were in-
creased after administration of the prebiotic lactulose
[4]. Probiotic groups in general were found to have a
lower relative abundance of Escherichia coli, suggesting
that the gut microbiome of piglets may have shifted
functionally and mechanistically [5]. Antimicrobials, re-
gardless of global concerns for antibiotic resistance, are
still widely used in pig farming as prophylaxis for bacter-
ial diseases and as growth promoters in addition to
therapeutic purposes [6]. Feasible and cost-effective al-
ternatives such as probiotics, which hold much promise,
are urgently needed.
Lawsonia intracellularis (L. intracellularis), an obligate
intracellular bacterium with a tropism for intestinal epi-
thelial cells, especially in the ileum [7], is of great im-
portance in pig production [8]. In pigs, L. intracellularis
is associated with ileitis, also known as proliferative en-
teritis, which manifests as an acute or chronic form [7].
In addition, subclinical infection of pigs is common and
often remains unnoticed while impacting production
and economic cost [9]. Transmission of L. intracellularis
among pigs occurs by the oral fecal route [10], most pig
herds are infected [8] and the disease may be exacer-
bated by co-infecting pathogens [11–14]. The high oc-
currence of L. intracellularis infection after weaning has
been associated with microbial dysbiosis resulting from
the change in feeding regiments [15]. Similarly, L. intra-
cellularis infection is also known to affect the gut micro-
biome [11, 15, 16].
Control of L. intracellularis infection is often accom-
plished by either vaccination or antimicrobial treatment.
High doses of antibiotics such as tiamulin, tylosin, chlor-
tetracycline, lincomycin and olaquindox have been
shown to be effective [17, 18]. Oral live and parenteral
inactivated vaccines are available to control L. intracellu-
laris [19, 20]. In vaccinated pigs, L. intracellularis shed-
ding is not completely eliminated, regardless of vaccine
type or vaccination route [21, 22]. A recent Danish study
found no clear beneficial effect of vaccination against
common swine pathogens including L. intracellularis
and the amount of prescribed antimicrobials [23]. More-
over, there is no study to date on the effect, if any, of
vaccines on the dysbiosis caused by L. intracellularis in-
fection. In addition, there is limited knowledge on the
effect of live attenuated L. intracellularis vaccine on the
microbiota of the intestine [11].
In a previous controlled L. intracellularis challenge
study we demonstrated changes in a) time to onset of
clinical pathology, b) levels of shedding and c) severity
of shedding associated with a commercial live L. intra-
cellularis vaccine supplemented via feed with one of
three Bacillus strains and control (non-supplemented/
non-vaccinated) compared to non-treated infected pigs
[24]. Here we examine the changes in the aforemen-
tioned groups in relation to microbiota structure of the
ileum using archived ileum content in a follow-up study.
Microbiota structure and taxonomic characteristics were
profiled using 16S rRNA gene amplicon sequencing with




Details on the experimental design (Table 1) and clinical
findings and L. intracellularis infection characteristics
including pathology and shedding results unrelated to
this investigation have been published [24]. In brief, 3-
week-old cross-bred pigs (the paternal line was a Hamp-
shire descent i.e. PIC®327, while the maternal line was
based on Landrace/Large White descents i.e. FAST 276)
were randomly assigned to one of six treatment groups
with 10–20 pigs each. The pigs were housed in four sep-
arate BSL-2 rooms with 1–3 pens (approximately 10 m2
each) of 10 pigs each equipped with a nipple waterer
and a self-feeder. Specifically, the T01-LAW, T02-LAW
and T03-LAW pigs were housed in a single room but in
three separate pens approximately 2 m apart from each
other. Similarly, the POS-CONTROL group was also
housed in a single room in two separate pens. The
NEG-CONTROL and VAC-LAW pigs were housed in
separate single rooms with a single pen each [24]. At 3
weeks of age, the pigs were either vaccinated with a
commercial oral vaccine against L. intracellularis (VAC-
LAW, n = 10), were supplied feed supplemented with
one of the three Bacillus probiotics (T01-LAW, B. amy-
loliquefaciens, n = 10; T02-LAW, B. licheniformis, n = 10;
T03-LAW, B. pumilus, n = 10), or remained non-treated
(NEG-CONTROL, n = 10; POS-CONTROL, n = 20). At
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7 weeks of age all groups, excluding the NEG-
CONTROL pigs, were challenged with gut homogenate
containing L. intracellularis by gastric gavage. The gut
homogenate, obtained from a commercial vendor, was
produced by collecting intestines from a field pig suffer-
ing from ileitis. The affected mucosa was collected and
processed (i.e. grinded and diluted), and the resulting
homogenate was passaged in experimental specific
pathogen free pigs to obtain mucosal scrapings with a
high L. intracellularis load free of other common pig
pathogens. A homogenized stock was used for inocula-
tion of all pigs to guarantee that each pigs was equally
exposed to microbial loads that potentially could have
been present in the inoculum. All pigs were euthanized
16 days post L. intracellularis challenge, at approxi-
mately 9 weeks old [24].
Measuring L. intracellularis infection kinetics
L. intracellularis shedding was evaluated by measuring
the bacterial load in rectal swabs. Rectal swabs were col-
lected at dpc 0, 2, 4, 6, 8, 10, 12 and 15 using polyester
swabs and stored in 5 mL plastic tubes containing 1 mL
of sterile saline solution at − 80 °C until testing. Testing
was done using a quantitative real-time PCR specific for
L. intracellularis as described [24]. Prior to analysis, gen-
omic copy numbers were log10 transformed to normalize
them. These values were used to calculate the total area
under the curve (AUC) for each group, one of the out-
comes utilized in this analysis. L. intracellularis associ-
ated histopathology was described using a combined
ileum lesion score based on microscopic lesions and
amount of L. intracellularis antigen within lesions. In
brief, individual scores of crypt enterocyte hyperplasia
(range from 0 = normal to 3 =marked with or without
crypt herniation into the submucosa), inflammation
(range from 0 = normal to 3 =marked cellular infiltrate
with or without submucosal infiltrate) and amount of L.
intracellularis antigen as determined by immunohisto-
chemistry (range 0 = no signal to 3 = most crypts in most
sessions with marked apical enterocyte labelling) were
combined for a maximal score of 9 [24].
Sample collection and sequencing
At necropsy, luminal ileum content was collected from
each pig approximately 10 cm anterior to the ileocecal
junction and stored at − 80 °C until use. In addition, the
inoculum stock, used to infect the pigs, was also proc-
essed and sequenced. Approximately 1 g (wet weight) of
the luminal ileum content from each pig or 1 g of the
challenge material was used to extract genomic DNA
using PowerMag DNA Isolation Kit (MO BIO Labora-
tories, Inc. Carlsbad, CA, USA) following the manufac-
turer’s instructions. The quality of the DNA was
assessed by Qubit 4 Fluorometer (ThermoFisher, Wal-
tham, MA, USA). The 16S rRNA amplicon library was
prepared as described [25] with minor modifications.
Briefly, the V4 region of the 16S rRNA gene was se-
quenced using the Illumina MiSeq sequencing platform
with v2 MiSeq cartridges to produce 2 × 250 bp paired
end reads. DNA was amplified by using the 515f/806r
primer set forward V4 (GTGCCAGCMGCCGCGG
TAA) and reverse V4 (GGACTACHVGGGTWTCTA
AT). The primers for library preparation were designed
based on the V4 primers, multiplex indices and Illumina
adapter sequences. Extracted genomic DNA was PCR
amplified with Schloss lab indices and AccuPrime™ Pfx
SuperMix (ThermoFisher, Waltham, MA, USA) using
the following cycling conditions: initial denaturation at
95 °C for 2 min followed by 30 cycles of denaturation at
95 °C for 20 s, annealing at 55 °C for 15 s, extension at






for the entire study duration)
Key events
Vaccination
3 weeks of age
− 28 dpcb
Challenge
7 weeks of age
0 dpc
Necropsy
9 weeks of age
16 dpc
T01-LAW 10 Base diet + Bacillus
amyloliquefaciensa
None Lawsonia intracellularis




T02-LAW 10 Base diet + Bacillus licheniformisa None
T03-LAW 10 Base diet + Bacillus pumilusa None




20 Base diet only None
NEG-
CONTROL
10 Base diet only None None
a Supplemented in the feed mill with 1 × 1012 colony forming units (CFU) of the respective Bacillus strain
b Day post Lawsonia intracellularis challenge
c Enterisol® Ileitis, Boehringer Ingelheim, serial number 3040187B, via the oral route by drenching 2ml of the vaccine, reconstituted as per manufacturer’s
instructions, into the mouth of each pig
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72 °C for 5 min, and a final extension at 72 °C for 10
min. The prepared library was purified using Agencourt
AMPure XP beads, (Beckman Coulter®, Brea, CA, USA).
Libraries were quantified using the Qubit dsDNA HS
assay kit (ThermoFisher, Waltham, MA, USA). The
pooled library was fed into the sequencing workflow
with 15% PhiX control library at a final concentration of
4pM, using MiSeq Reagent Nano kit v2 (Illumina, San
Diego, CA, USA) for a 500 cycle (2 × 250 bp) run. Cus-
tom sequencing primers designed on the V4 region were
utilized during the sequencing procedure, together with
MiSeq sequencing primers (Illumina, San Diego, CA,
USA) as follows: read 1 primer (TATGGTAATTGTGT
GCCAGCMGCCGCGGTAA), read 2 primer (AGTCAG
TCAGCCGGACTACHVGGGTWTCTAAT) and index
primer (ATTAGAWACCCBDGTAGTCCGGCTGACT-
GACT). Raw data was de-multiplexed based on dual in-
dices to generate two FASTQ files, R1 and R2, for each
sample.
Sequence processing using QIIME-2
The paired end reads from the sequencing step above
were processed using the Quantitative Insights Into Mi-
crobial Ecology-2™ (QIIME-2) software [26]. The raw
reads and the corresponding experimental metadata
were combined using a manifest generated QIIME-2
analysis file. The reads were then de-replicated and
chimeric sequences were removed before the denoising
was done in DADA2 [26]. The resultant feature tables
were used to identify the appropriate sequence depth at
which the subsequent analyses would be performed. In
addition, output data from a rarefaction analysis step
was used to identify and remove spurious sequences at
the appropriate sequence depth. Alpha and beta diversity
indices as well as the operational taxonomic unit (OTU)
phylogenetic were obtained by following the QIIME-2
workflow [26]. OTU taxonomic classification was done
using a naïve Bayes classifier trained on the SILVA data-
base (vMarch 2020) at 97% similarity [27]. First, a train-
ing dataset using the sequencing primers was extracted.
The classifier was then used after the training to assign
taxonomy to our OTU dataset.
Ileal microbiota structure analysis
The analysis of the microbiota community structure was
based on characteristics of the alpha and beta diversities.
In brief, data from QIIME-2 was exported into the R
statistical package (v3.5.1). Four files, including the taxo-
nomic map, the OTU biome table, the experimental
metadata and the rooted phylogenetic tree, were com-
bined to generate a phyloseq object [28] which was used
for downstream analysis. To analyze the alpha diversity,
we first normalized the taxa abundance using the “rela-
tive” option in the normalize_data function from the
“microbiome” R package [29]. Then the plot_anova-di-
versity function from the same package was used with
the adjusted level of significance set at ≤0.05 for species
richness (observed OTU count), the Simpson index and
the Shannon index [30]. Pairwise comparison between
treatment and each alpha index was done using the non-
parametric Wilcoxon test with a significant p-value set
at < 0.05 [31]. We also explored four beta diversity indi-
ces, i.e. Bray-Curtis dissimilarity, Jensen-Shannon diver-
gence (JSD), double principal coordinate analysis
(DPCoA), and weighted UniFrac distances, to
characterize the impact of treatment on microbiota
structure [32–34]. Each of these beta diversity indices
exploits slightly different aspects of the microbiota struc-
ture and a comparative examination of these tools
allowed us to determine the extent to which community
structural variations are explained by treatment or sex.
Treatment or sex associated microbial structural changes
To assess multivariate associations of experimental fac-
tors and microbial structural changes, a permutation
multivariate analysis of variance (PerMANOVA) model
with the Adonis function (9999 permutations) was used
in the “microbiome” package in R. Here a model was
run for each of the beta diversity indices with the aim to
assess the individual and cumulative variation explained
by the factors (sex, treatment) used in this study.
Taxonomic profiles of ileal microbiota
The “metacoder” package (v0.3.2) in R [35] was used to
profile the ileal microbial taxonomy, and taxonomic as-
signments (pan-phylogenetic) and their abundances
(heat tree) were plotted based on treatment. This
allowed for visualization of changes in abundance of
each phylogenetic tree branches in each treatment
group. In addition, mean abundances per family were
computed and visualized using the “ComplexHeatmap”
package (v2.5.1) as described [36]. The assumption for
this analysis was if the hierarchical clustering of taxa re-
capitulates the treatment groups, then there should be a
strong relationship between the taxonomic profiles and
treatment groups [37].
Comparison between L. intracellularis clinical
characteristics and ileal microbiota
To identify any relationship between the microbiota
characteristics and the clinical signs of infection, i.e.
histopathology and fecal shedding of L. intracellularis
[24], we used a correlation analysis and the multinomial
logistic regression to fit a model using the “ggbupr”
package (v0.4.0) in R. First, we assessed the correlation
between shedding and histopathology, then examined
how each is associated with primary microbiota parame-
ters such as abundance, diversity and richness as well as
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secondary parameters such as clustering. Parameters and
characteristics were defined as directly or inversely cor-
related and a statistical significance of p < 0.05 deter-
mined the significance of the association. This allowed
us to identify treatment-mediated parameters associated
with reduced shedding and histopathology.
Results
Summary description of the study group
A total of 70 pigs, sero-negative for L. intracellularis,
were included. Each group contained 10 animals, exclud-
ing the POS-CONTROL group which contained 20 ani-
mals. The pigs were purchased from a commercial farm
in the Midwest of the US and were cross-bred pigs.
Overall, 54.3% (38/70) of the pigs were male and 45.7%
(32/70) were female. Samples used for this study were
collected from 9-week-old pigs of which the majority had
been experimentally challenged with L. intracellularis
16 days earlier. They spent 44 days on their specific diet
with or without probiotic supplementation.
Infection kinetics and pathology associated with L.
intracellularis
On arrival, all pigs were free of L. intracellularis anti-
bodies and DNA as determined by ELISA on serum and
PCR on fecal samples [24]. By the time of inoculation 4
weeks after L. intracellularis vaccination, all VAC-LAW
pigs had seroconverted and, at necropsy, 10–65% of the
pigs in all other challenged groups were also seroposi-
tive. Successful L. intracellularis challenge was con-
firmed by a high prevalence of pigs shedding L.
intracellularis with the highest bacterial DNA levels de-
tected in POS-CONTROL pigs, VAC-LAW pigs and
T01-LAW pigs (Additional file 1). There was a delay in
onset of shedding in T02-LAW and T03-LAW groups,
which was reflected in less severe macroscopic and
microscopic lesions (Additional file 2), reduced intrale-
sional L. intracellularis antigen levels and a lower area
under the curve for bacterial shedding [24].
16S rRNA gene sequencing output statistics
From the tissue homogenate used for inoculation of the
pigs, a total of 127 bacterial taxa were identified of
which 108/127 taxa contributed less than 1% of the
overall population (Additional file 3). L. intracellularis
accounted for 37.5% of the taxonomic abundances in the
inoculum. From the 70 ileal content samples, 4.4 million
sequences were generated, 89% of which had a quality
score of Q30 and above. Preliminary assessment without
a sequence depth filter showed that the sequences clus-
tered into 2241 unique OTUs with an average frequency
of 57,237. At an even sampling depth of 10,000, 69 sam-
ples and 1025 unique OTUs were retained, and their dis-
tribution according to treatment is shown in Fig. 1. The
refraction curves in Fig. 1a indicate that T03-LAW pigs
and the NEG-CONTROL pigs had a higher diversity
(Shannon index); indeed, the former had nearly four
times the observed OTU count as compared to the
VAC-LAW group. Similarly, and as indicated in Fig. 1b,
ileal content from male pigs appeared to have a higher
diversity (Shannon index); however, this was not statisti-
cally significant compared to female pigs.
Microbiota structure of the ileum
Alpha diversity
The mean species richness, Simpson index, and Shannon
index across all groups were 93, 0.53 and 1.9, respect-
ively. A comparison between groups showed significant
differences (p < 0.001) in all three alpha diversity indices
as shown in Fig. 1c except richness between NEG-
CONTROL and POS-CONTROL groups. A significant
difference in diversity was evident between NEG-
CONTROL and POS-CONTROL pigs. However, the lar-
gest differences were observed between T03-LAW and
POS-CONTROL. Although significant differences in
richness existed between T03-LAW and VAC-LAW for
the Shannon index, the same was not true for the Simp-
son index. There were no statistical differences between
male and female pigs (Fig. 1d). Overall these results sug-
gest that treatment was associated with an individual’s
microbiota variations, however there was no impact of
sex.
Beta diversity
Distinct clustering, corresponding to treatment, disap-
peared when increasing the total explained variance
(Fig. 2). For example, clustering disappears at 69.9% (Fig.
2c), but is discernable between 11 and 20.8% (Fig. 2a
and b), suggesting that the upper limit of variance attrib-
utable to treatment groups is between 20.8 and 69.9%.
Note here that clustering is much more defined for pigs
in the T03-LAW group, while T01-LAW and T02-LAW
share a cluster, and the NEG-CONTROL, POS-
CONTROL and VAC-LAW groups share the remaining
cluster. The multivariable analysis of association was
therefore restricted to the first three beta diversity
indices.
The PerMANOVA analysis (Table 2) indeed shows
that treatment as an experimental variable explained
26.8, 28.8 and 35.7% of the variation in microbiota struc-
ture as estimated using the Bray-Curtis index, Jensen-
Shannon divergence, and DPCoA distances, respectively.
This agrees with the univariate analysis in Fig. 2 and
suggests that treatment explained 27–36% of the micro-
bial structural variation. Therefore, since treatment here
is associated with changes in alpha and/or and beta di-
versities, treatment significantly impacted structural
changes in the ileal microbiota.
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Taxonomic profiles of ileum microbiota
The 1025 OTUs clustered into 14 phyla, 85 families and
178 genera. At the phylum level Firmicutes and Bacterio-
detes accounted for more than 75% of the abundance,
other phyla included Proteobacteria and Actinobacteria.
At the family level, Ruminococcaceae, Prevotellaceae,
Lachnospiraceae, Clostridiaceae, and Lactobacillaceae
were the most abundant. The heat trees in Additional file
4 show the phylogenetic relationships of ileal microbiota
by treatment i.e. thick dark green branches represent the
core microbes. T03-LAW had an overall enrichment
shown as thick dark green branches through the heat tree
(Additional file 4), indeed T03-LAW accounted for 87% of
the OTUs and genera observed in this study. On more
granular or closer analysis, the enrichment exhibited by
T03-LAW is discernible as cluster 1 (Fig. 3), although a
few T03-LAW pigs are also present in clusters 2 and 3
(Fig. 3). The core, i.e. genera observed in 85% of the sam-
ples, was composed of 38 genera including Clostridium,
Lawsonia, Lactobacillus, Streptococcus, Bifidobacterium
and others. In this regard we also observed that clusters 1
and 3 had an enriched core whereas cluster 5 had a de-
pleted core (Fig. 3). In summary, clustering by taxonomic
abundance was mainly associated with T03-LAW, which
also exhibited the highest taxonomic diversity.
Ileal microbiota and clinical characteristics of L.
intracellularis
A direct correlation between histopathology in the ileum
and fecal shedding of L. intracellularis is demonstrated in
Fig. 4a. This relationship varied for the individuals in each
of the five clusters defined in Fig. 3. For example, the high-
est diversity is present in cluster 1 (almost exclusively
made up by T03-LAW), and core enrichment is present in
cluster 3 whereas core depletion can be noted in cluster 5.
In general, cluster 1 was associated with lower histopath-
ology scores and shedding. It appears that changing the
core genera population does not directly lead to a change
in clinical presentation. Cluster 4 was dominated by mem-
bers of the POS-CONTROL group. Generally, there was a
discernible relationship between microbial abundance and
clinical characteristics (shedding and histopathology) (Fig.
4c and e), however at the family level, there were signifi-
cant correlations with Clostridiaceae, Erysipelotrichacea
and Streptococeae (Fig. 4d and f). The direction of these
correlations varied, for example an inverse correlation was
seen between clinical characteristics and the abundance of
Clostridiaceae for all treatment groups except for the
NEG-CONTROL group which showed a flat (neutral) cor-
relation for shedding and the histopathology score. The
unit increase in abundance of Streptoccocaeae and
Fig. 1 Changes in the ileal microbial structure associated with treatment groups. a Rarefaction curves of alpha diversity indices, i.e. observed
OTUs and Shannon index, grouped by treatment. b Rarefaction curves of alpha diversity indices grouped by gender. c Boxplots of pairwise
comparison of the treatment alpha diversity indices using Wilcoxon’s non-parametric test where asterisks represent an adjusted P value less than
0.05*, 0.001**, 0.0001***. d Boxplots of the gender alpha diversity indices
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Erysipelotrichacea was associated with a 0.25–0.35 and
0.24–0.32 log reduction in shedding and histopathology
respectively (Fig. 4d and f). In groups T01-LAW, T03-
LAW and VAC-LAW the abundance of Streptococcaceae
was inversely correlated to shedding and histopathology,
whereas the NEG-CONTROL group as well as the POS-
CONTROL group, when looking at shedding only,
showed no correlation with clinical signs. The opposite
seems to be true for Erysipelotrichacea, where only T02-
LAW and T03-LAW show a neutral correlation whereas
the POS-CONTROL is inversely correlated. An inverse
correlation was also observed for Rummincococeae (T01-
LAW, T02-LAW, T03-LAW, VAC-LAW), Coriobacteria-
ceae (T01-LAW, T02-LAW, T03-LAW, VAC-LAW,
POS-CONTROL for shedding and family abundance only)
and Peptostreptococaceae (T01-LAW, T02-LAW, T03-
LAW for histology and family abundance only, VAC-
LAW, POS-CONTROL) (Additional files 5 and 6). An in-
verse correlation between shedding and the diversity of
the ileal microbiota was identified (Fig. 5a). Indeed, a unit
increase in the Shannon index was associated with a 2.8
log reduction of L. intracellular is DNA copy numbers
shed in the feces. The direction of this relation was heavily
influenced by T01-LAW. Although T03-LAW, T02-LAW
and VAC-LAW exhibit a direct relationship, T03-LAW
and to some extent also T02-LAW were characterized by
lower levels of shedding. Critically, for shedding both con-
trol groups exhibit a neutral relationship between clinical
characteristics and diversity which suggests that the ob-
served effect is due to the treatment. It is noteworthy that
Fig. 2 Comparative analysis between beta diversity indices and treatment groups. a-c Indication of the level of clustering and how treatment
groups map to gender. d The level of clustering by treatment as a proxy for how much variation is explained by treatment group
Table 2 Results of the PerMANOVA analysis using beta diversity indexes
Bray-Curtis Jensen-Shannon divergence DPCoA distances
DF R2 P-value DF R2 P-value DF R2 P-value
Experimental factor
Treatment 5 0.268 0.0001 5 0.357 0.0001 5 0.288 0.0001
Sex 2 0.006 0.8063 2 0.006 0.6516 2 0.008 0.513
Model
Residuals 63 0.72 63 0.635 63 0.703
Total 69 1.00 69 1.00 69 1.00
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the correlation between histopathology and diversity was
not statistically significant (p = 0.063) but the trends were
similar compared to shedding.
Discussion
In this study, ileum microbiota characteristics in L.
intracellularis infected pigs under different experimental
treatment regiments were defined and characterized. We
specifically compared possible prophylactic interventions
to prevent L. intracellularis associated disease as op-
posed to traditional therapeutic methods such as anti-
biotic treatment. In future it may be worthwhile to
repeat this study and to add a traditional antimicrobial
treatment as an additional group. The ileum, as the pri-
mary site of L. intracellularis infection in pigs [38], was
the selected anatomical location in this study. Our
approach consisted of collecting ileum content from
9-week-old pigs, 16 days after experimental infection
with L. intracellularis and 44 days post commercial L.
intracellularis vaccination (VAC-LAW) or the start of
three different probiotics (T01-LAW, T02-LAW, T03-
LAW) which were added to the regular base diet
given to pigs in all groups. This differs from other L.
intracellularis studies focusing on the enteric micro-
biome which investigated fecal [11] or caecum and
colon microbiota [16], or analyzed the distal ileum
content using terminal restriction fragment length
polymorphism [15] and provides a broad snapshot of
L. intracellularis infection dynamics at the site of
colonization. We specifically examined the bacterial
community as earlier L. intracellularis experiments in
gnotobiotic pigs suggested that a certain microbial
background is required for L. intracellularis infection
to establish [38]. The factor “treatment” was used to
analyze the changes in ileum microbiota using 16S
rRNA gene sequencing. We then linked observed
changes to clinical phenotypes of L. intracellularis in-
fection including fecal shedding and histopathology in
the ileum. Overall, we observed a strong association
between treatment and changes in ileum microbiota
structure based on alpha diversity indices. These
changes were significant and not limited to richness
(i.e. the number of unique OTUs) but also to even-
ness and relative abundance. For example, richness
was highest in T03-LAW and lowest in VAC-LAW
(Fig. 1c). However, VAC-LAW had a higher average
Simpson index compared to T01-LAW even though
the unique OTU count in VAC-LAW was signifi-
cantly lower. It remains puzzling why, in this study,
the vaccinated group had the lowest OTU count but
at the same time had a more even distribution of
bacteria and how this impacted the overall outcome.
A more even and diverse ileum microbiota may be benefi-
cial for pigs infected with L. intracellularis as has been ob-
served in relation with other pathogens [39, 40].
Microbiota changes were associated with specific clinical
Fig. 3 The genus level microbial richness characterized in this study clustered by abundance levels. The clusters are linked to the treatment
groups and sex. Note that the first 38 genera on the x-axis represent the core i.e. genera present in at least 85% of the individuals
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Fig. 4 (See legend on next page.)
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phenotypes as shown in the downstream analysis; specific-
ally, increased diversity was associated with reduced
histopathology lesions and fecal shedding. It is likely
that the presence of specific organisms in T03-LAW
pigs resulted in the desired effect on clinical presenta-
tion. It has been previously shown that AUC mea-
surements and shedding duration were significantly
increased in VAC-LAW pigs compared to T02-LAW
and T03-LAW pigs; 40% of the VAC-LAW pigs had
severe microscopic ileum lesions compared to 10% of
T02-LAW and 0% of T03-LAW animals [24]. The
reason for these previous observations is unknown. T01
was supplemented with B. amyloliquefaciens, T02 was
supplemented with B. licheniformis, and T03 was given B.
pumilus. While these all belong to the Bacillus species, it
is well acknowledged in the probiotic literature that even
members of the same species, i.e., different strains, differ
in their properties and utility as a probiotics [41].
Fig. 5 Relationship between L. intracellularis phenotype, including a shedding and b histopathology (microscopic ileum score), and their
corresponding ileal microbiota diversity. Groups are colored by treatment and R represents the correlation coefficient and the corresponding
p value
(See figure on previous page.)
Fig. 4 Association between Lawsonia intracellularis phenotypes i.e. histopathology and shedding and ilea microbiota taxonomic abundance
(log10) at the family level. All treatment groups are color coded. R represents the correlation coefficient and the corresponding P value. a shows
the relationship between shedding and pathology (microscopic ileum score) and b shows how this varies depending on taxonomic clustering
and treatment group. c Overall comparison of shedding (log10) and microbial abundance. d Same relationship as in A faceted by selected
number of microbial families (full profile in Additional files 4 and 5). e Overall comparison of pathology (microscopic ileum score) and microbial
abundance. f Same relationship as in c faceted by selected families
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Additional in vivo but also in vitro studies are required to
confirm the obtained results and to define the effect/
mechanism of each of these Bacillus species on the
microbiome and more specifically on L. intracellularis to
identify possible mechanisms leading to reduction of L.
intracellularis infection, shedding and lesions.
Similarly, we exploited the subtle methodological dif-
ferences in analyzing beta diversity to define a range of
variation likely attributable to treatment. Specifically, in
this study, treatment explained between 26 and 36% of
the population variation. To put this in context, the ef-
fect size of probiotic treatment is similar to the effect
size of bile acid on the intestinal microbiome [42]. In
this regard, the largest change in beta diversity was seen
for T03-LAW while changes for T01-LAW and T02-
LAW were similar, hence the co-clustering.
Our approach assumed that clustering by richness and
abundance corresponding to treatment is indicative of a
strong taxonomic effect for the experiment. The extent
to which treatment impacted the ileal microbial struc-
ture differed for each group. These differences poten-
tially define the exploitable usefulness of these
treatments, specifically in augmenting clinical outcomes
to control L. intracelluaris in pig herds. For example,
significant differences were observed between POS-
CONTROL and NEG-CONTROL for the alpha diversity
indices and discernible clusters were identified for the
beta diversity indices. However, intriguingly, the micro-
bial structural changes between POS-CONTROL and
VAC-LAW were comparable. Members of the T03-
LAW almost exclusively grouped in cluster 1 (Fig. 3)
which accounts for a considerable amount of the
overall observed richness. This dramatic increase in
richness was associated with lower shedding and lower
histopathology scores. T03-LAW appears to break the
direct relationship (positive correlation) observed in
all other L. intracellularis infected pigs between shed-
ding and histopathology. The mechanisms for this are
currently unknown but among other reasons could be
due to a direct interaction of probiotic bacteria (or
their metabolites) with either L. intracellularis, the
established microbiome, or both. Alternatively, other
microorganisms, induced by the probiotic bacteria or
their metabolites, could have a major impact. Also,
the probiotic bacteria could directly affect the protect-
ive biofilm formation on the enteric mucosal surface,
such as changing the redox potential, resulting in an
unfavorable environment for L. intracellularis. It may
also be beneficial to increase the microbiota richness
for the robustness of a niche in warding off a patho-
gen invasion. It is recognized that enteric pathogens,
including L. intracellularis, have the potential to alter
the bile acid metabolism [43]. Physiologically, 95% of
bile salts are reabsorbed by the jejunum and ileum
epithelium by active and passive transport and the small
intestinal microbiome plays a major role in the bile acid
metabolism [44]. Hence, it is likely that the bile acid me-
tabolism is affected by the damage to the small intestinal
epithelium due to L. intracellularis infection, the disrup-
tion of the physiological microbiome (dysbiosis) at that
site brought on by the infection or both [15]. The favor-
able microbial composition and increased microbial diver-
sity associated with probiotic treatment could mitigate L.
intracellularis infection by impacting the bile acid metab-
olism and other similar physiological processes. In this
particular context further research is required to identify
the microbial combination of probiotics and mechanistic
basis for these effects.
Shifts in the ileal core genera were associated with
changes in the threshold for shedding level, i.e. the clus-
ters with the most depleted core (cluster 5) and the most
enriched cores (clusters 1 and 3). This suggests that de-
pleting the ileal core genera results in a higher threshold
for shedding. It is difficult to compare the core genera
across studies. Besides age, commonly studies are done
in pigs around weaning [45, 46], housing and diet may
also impact core genera. Moreover, it has been recently
determined that when defining the core microbiome in
pigs, differences in study protocols have a significant im-
pact and standardization of experimental techniques ap-
pear to be important [47]. Nevertheless, using a meta-
analysis of 20 data sets, several shared genera such as
Prevotella, Clostridium, Alloprevotella, and Ruminococ-
cus were identified [47]. A more recent study, based on
analysis of freshly collected feces, identified a pig core
microbiome of 69 bacterial features present in all growth
stages [48]. Besides confirming the earlier core genera
findings, at the family level the top three families were
Prevotellaceae, Ruminococcaceae, and Lactobacillaceae
[48]. The analysis in this study does not suggest a major
effect of the core microbiota on clinical presentation
other than threshold differences in shedding detection
(cluster 3 enriched and cluster 5 depleted in Fig. 4b).
In this study it was established that a direct relation-
ship exists between pathology and shedding and identify-
ing microbial factors that disrupt it provides a
foundation for limiting the impact of this infection. The
precise mechanism of this microbial interaction is un-
known. The data obtained here will be useful to design
future experiments in an attempt to further reduce bac-
terial shedding and pathology. This perhaps could ad-
vance probiotic supplementation to limit the impact of
infectious diseases in food production. Limiting pathology
arguably reduces not only the adverse effects on an
animal’s productivity but also shedding and thus limits
transmission to other pigs. In this regard, T03-LAW (clus-
ter 1) appears to be the only treatment group in which the
shedding dynamics were reduced. At the family level, a log
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increase in abundance of Clostridiaceae, Streptoccaceae or
Erysipelatricheae was associated with 3.9, 3.1 and 3.4 log
reduction in copies of L. intracellularis shedding and
pathology rank, respectively. In particular, reduction
in shedding and pathology in the VAC-LAW group
appeared to be influenced by the increase in abun-
dance of Clostridiaceae. A similar but weaker rela-
tionship was noted for T01-LAW and T02-LAW. In a
previous study, analysis of the microbiota of L. intra-
cellular is vaccinated pigs showed that vaccination led
to changes in the abundance of Clostridium species,
including Clostridium butyricum [11] which is in
agreement with the results of this study. However, an
increase in abundance of the three aforementioned
families was not associated with shedding or path-
ology (reduction or increase) for T03-LAW.
An increase of one unit in the Shannon diversity
index resulted in a 2.8 log reduction in shedding in
this study. In other words, by increasing diversity one
could reduce shedding of L. intracellularis. In
addition to T03-LAW, a reduction in shedding associ-
ated with increased diversity was also evident for
T01-LAW and T02-LAW. An increase in diversity
was however associated with increased shedding
among VAC-LAW pigs and this still requires an ex-
planation. Perhaps this could reflect the effect of a
longer term dysbiosis as the VAC-LAW group was
first exposed to attenuated L. intracellularis before
being exposed to pathogenic L. intracellularis chal-
lenge. In addition, the VAC-LAW group did manifest
associated changes in the ileal microbiota after L.
intracellularis challenge (Additional file 4) which war-
rants further studies. Crucially, the comparison between
clinical phenotypes and ileal microbiota diversity showed
that both control groups (NEG-CONTROL, POS-
CONTROL) were not affected by this relationship. The
direction and strength of the relationships observed with a
treatment, i.e. the associated microbial community, there-
fore reflects its true impact.
In this study the pigs were not challenged with a
pure L. intracellularis inoculum obtained by in vitro
culture but rather with ileum mucosa scrapings,
from a commercial vendor, containing L. intracellu-
laris obtained from pigs deliberately infected under
experimental conditions to produce the inoculum
stock. This was done because in vitro propagation of
L. intracellularis is difficult and only successfully
performed in few labs worldwide [17, 49], wild-type
strains are often attenuated after passaging [50], and
clinical ileitis can be difficult to reproduce with pure
cultured inoculum [51] with some exemptions [52].
The important comparisons in this study were be-
tween the T01-LAW, T02-LAW, T03-LAW and
POS-CONTROL groups which all received an
identical inoculum. 16 s rRNA gene amplicon se-
quencing obtained from the inoculum indicate that
37.5% of the stock was L. intracellularis whereas
other bacteria where only present in small percent-
ages (Additional file 3).
A potential application of the study findings in-
cludes microbiota augmentation to modify pathology,
shedding and, by extension, L. intracellularis trans-
mission. This may have profound implications for the
dependence on antibiotic use to control infectious
diseases in livestock production systems. However, ex-
tensive research will be required to optimize probio-
tics (and likely also prebiotics) outside the realm of
controlled experimentation. Ultimately such scalable
innovation means livestock will be raised without ad-
verse environmental effects while also minimizing the
contribution to the evolution of antibiotic resistance.
In this regard, our findings indicate the potential use-
fulness of microbial families such as Clostridiaceae,
Streptoccaceae, Erysipelatricheae, Rummincococeae,
Coriobacteriaceae and Peptostreptococaceae in aug-
menting clinical outcomes during L. intracellularis
infections.
Conclusions
In this study, significant effects on the ileal micro-
biota structure were observed during experimental in-
fection of pigs with L. intracellularis, either with
prophylactic treatment in the form of a commercial
live L. intracellularis vaccine or in-feed probiotics.
These changes exhibited as taxonomic shifts and in-
cluded, but were not limited to, core and accessory
genera depletion or enrichment. We observed that
microbial changes such as diversity and richness had
an inverse correlation with clinical characteristics
such as ileal histopathology and fecal shedding. The
extent to which this relation manifested varied de-
pending on treatment, which raises the potential for
using microbial manipulation to decrease pathology
and shedding. Modulating these clinical parameters
appears to be the foundation to limiting disease trans-
mission as well as promoting individual animal resili-
ence to disease. Further studies need to be done to
explore the causal relationship and underlying mecha-
nism(s) of probiotic feed supplementation on L. intra-
cellularis induced ileal lesions. To unravel the
complex associations between microbial diversity and
L. intracellularis infection/pathogenesis, a longitudinal
pig study with suitable design, such as sampling at
different time points by staggered sacrifice of pigs
within a group, introduction of the probiotic feed
intervention at different time points before or after L.
intracellularis infection, or ileal content transfer in
addition to other tools would also be required.
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